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SHORT COMMUNICATION
Intra-hepatic-arterial infusion of misonidazole - an experimental study of
regional radiosensitisation by intraarterial embolisation
Y. Wang', J. Tian2, Q. Wang', Z. Xing3, L. Yang4, S. Wang', D. Yang' & G. Cheng'
'Department ofRadiotherapy, Chinese PLA General Hospital, Beijing 100853; 2Department ofNuclear Medicine; 3Department of
Pathology; 4Department ofDiagnostic Radiology, Chinese PLA General Hospital, Beijing 100853, China.
Summary The purpose of this study was to generate a selective radiosensitising effect by the intra-hepatic-
arterial infusion of misonidazole (MISO). MISO (10 mg) was infused after transcatheter hepatic-arterial
embolisation into the livers of rabbits bearing VX2 liver cancer. This procedure was followed by 15 Gy
electron irradiation. Evaluation of tumour volume and histological examination was carried out on the 7th
day after treatment. The greatest tumour response was obtained in the group which received MISO followed
by radiation and was characterised by extensive fibrosis around the tumour and nearly complete tumour
necrosis. Liver cell regeneration was also noted in adjacent liver tissue. The advantages of regional infusion of
MISO following hepatic-arterial embolisation are: (1) Selectivity increased radiosensitivity of liver cancer
alongside very low drug concentration in the plasma. (2) Reduced or absent deleterious side effects of MISO
with higher tumour/normal tissue ratios of drug concentration. (3) Reduced cost due to the lower dosage of
MISO required for regional infusion.
For the treatment of liver cancer, many chemotherapeutic
agents have been administered via the hepatic artery. In this
technique the increase in concentration of anticancer drugs at
the target site is an inverse function of regional arterial blood
flow (Ensminger & Gyves, 1984). In view of this, we have
carried out a study to determine the possibility of obtaining a
selective radiosensitising effect by intra-hepatic arterial
infusion of misonidazole (MISO), an agent which has been
shown to display a steep dose-response for radiosensitisation
but also for neurotoxicity. Encouraging results have been
obtained by regional administration of 10 mg MISO to rab-
bits bearing liver tumours and treated with 15 Gy of electron
irradiation.
Materials and methods
Twenty-two male New Zealand white rabbits weighing 2.0-
2.5 kg were used. The VX2 tumour cell line was maintained
by serial transplantation into the hind leg muscle. The rabbits
were anesthetised by injection of thiopentalum natricum
(20 mg kg-1, i.v.) for laparotomy and finely minced frag-
ments of tumour were inoculated into the left medial hepatic
lobes. Fourteen days after inoculation the tumours were 2.0-
2.5 cm in diameter as measured from CT scans, accordingly
the operation for transcatheter hepatic-arterial embolisation
was performed on the 14th day after the tumour inoculation
under sodium pentobarital anesthesia (30 mg kg-', i.v.). A
longitudinal incision along the right inner inguinal was made,
exposing the right femoral artery. A 2 F polyethylene guiding
catheter connected to a 1 ml syringe was inserted via a very
small incision into the artery, the position of the guiding
cathether being monitored angiographically by the injection
of 60% Urografin under fluoroescopic control. The final,
critical positioning of the catheter was made when the tip of
the catheter reached the space between the 12th thoracic
vertebra and the first lumbar vertebra, thereby making cer-
tain that the entry of contrast agent into the hepatic-artery
was after any arterial divisions. Microspheres were then
injected. An angiograph of rabbit common hepatic artery is
shown in Figure 1. Injection of the agents after selective
catheterisation was monitored under fluoroscopy to avoid
movement of the catheter tip.
Macroaggregated albumin (MAA) microspheres, 20-50#m
in diameter with cross-linked configuration, were chosen for
embolisation. They were suspended in normal saline at a
concentration of 3 x 106/0.5 ml for each animal. MISO was
dissolved in normal saline in a 35'C water bath just before
infusion. Five groups were used: (1) control (n = 5), 1.0 ml
normal saline was injected into the common hepatic artery;
(2) embolisation alone (n = 4), MAA microspheres were
injected slowly into the common hepatic artery through the
catheter followed by 1.0 ml normal saline; (3) MAA plus
MISO (n = 4), MISO (10 mg) was infused immediately after
MAA injection in a volume of 1.0 ml for each animal. To
prevent extrahepatic spillover, a prolonged injection at a rate
of 1.4 ml min-' was used; (4) MAA plus irradiation (n = 5),
MAA injection was followed by 1.0 ml normal saline
infusion. 15 Gy electron radiation (12 MeV Varian-1800) was
delivered to the tumour site 10 min after the operation. The
radiation field was 4.5 cm square; (5) MAA plus MISO plus
irradiation (n = 4), 10 mg MISO in 1.0 ml for each animal
was perfused after MAA injection and followed by 15 Gy
electron irradiation with the same interval as group 4. In
each case, after flushing with heparin saline, the catheter was
withdrawn at the end of drug perfusion. The rabbit's right
femoral artery was ligated and the incision was closed. The
animals were sacrificed on the 7th day after treatment, their
livers were removed and the tumour volumes were measured.
Conventional histological examination of the tumours and
adjacent liver tissue was carried out.
To confirm the embolisation effect of MAA, groups of
rabbits, five normal and five bearing VX2 liver cancer, were
used for a radionuclide study of hepatic blood flow. A large-
field-of-view gamma camera with a high resolution collimator
was used. The rabbits were placed under the collimator after
positioning of the catheter. 9"'Tco4- (3.7 x 104 Bq) was per-
fused into the common hepatic artery before MAA injection.
The rabbit's liver, the tumour region (left lobe) and the heart
were scanned simultaneously. Further injection of 3.7 x 105
Bq 9'Tco4- was administered immediately after MAA infus-
ion and the scanning procedure was repeated.
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Figure 1 Angiograph of rabbit common hepatic artery.
Results
The hepatic blood flow pre- and post-MAA injection was
evaluated by regional clearance of '"Tc radioactivity, which
was represented as a mono-exponential curve as a function of
time (Leme, 1984). Analysis of data is presented in Table I.
For each curve of regional '"mTc clearance a, the intercept of
the curve, represents the diffusion volume of radionuclide in
the organ; 1, the slope, represents the clearance rate for each
area indicating the blood flow rate. Table I shows that values
of a were slightly decreased after MAA infusion, suggesting
that the diffusion of radionuclide in those sites was somewhat
restricted. P dropped significantly in the tumour area imply-
ing that the regional blood flow was blocked to a certain
degree and that the blood flow was shut down in the liver
especially at the tumour site.
Table II shows the comparison of rabbit VX2 tumour
volumes on the 7th day after treatment. The tumour volume
was evaluated according to the formula V = ab2 (a: the maxi-
mum diameter; b: the minimum diameter) (Carlsson et al.,
1983). There was a clear tumour response in the group
receiving MISO plus irradiation following MAA intraarterial
embolisation (P<0.05). No significant difference was observ-
ed between the tumour volumes in the control group and the
group receiving MAA embolisation alone (P>0.05). Com-
Table II The volume ofrabbit VX2 liver tumours on the 7th dayafter
regional infusion of MISO
No. of Tumour volume
Group Treatment rabbits (cm3) mean±SD
I # * Control 5 32.3± 16.5
2 #** MAA alone 4 22.5±9.1
3 ** MAA + MISO 4 12.9±3.0
4 * MAA+ 15Gy 5 11.2±9.8
5 * MAA+MISO+ 15Gy 4 7.1±2.1
Note: Difference among * groups were analysed using method of
analysis of variance, P<0.05. Difference between # groups was
analysed by t-test, P>0.05. Difference between ** groupswasanalysed
by t-test, 0.05<P<0.1.
pared with the group receiving MAA alone the tumour
volume in rabbits treated by MAA plus 10 mg MISO was
smaller (P<0.1).
Histological evaluation carried out by a pathologist con-
firmed that the greatest effect was seen in the group treated
with MISO followed by irradiation following MAA intra-
arterial embolisation. The effect was characterised by com-
plete necrosis inside the tumour with abundant encircling
fibroplasia (Figure 2). Liver cells with double nuclei and
deeper cytoplasmic staining were observed in adjacent liver
tissue (Figure 3), suggesting the repair and regeneration of
associated normal liver tissue. There signs of regeneration
were also noticed in the group receiving MAA followed by
irradiation. In the groups treated with MAA plus MISO or
with MAA plus irradiation, areas of necrosis inside the
tumour and surrounding moderate or obvious fibroplasia
were observed. Another interesting finding shown in Table
III was the obvious degeneration of liver cells in the area
around the central vein accompanied by dilatation of the
cavity and congestion in all groups receiving MAA embolisa-
tion (Figure 4). This phenomena was thought to be caused
by a transient block of nutrient-supplying vessels to the liver
tissue. The extent of tumour histological change was propor-
tional to the effect on tumour volume in each group studied.
Figure 2 Complete necrosis inside the tumour with abundant
encircling fibroplasia was observed on the 7th day after MISO
infusion plus irradiation following.MAA intraarterial embolisa-
tion. H and E,x 10.
Table I Comparison of 99'Tco4- clearance of heart, liver and tumour (left lobe) pre- and
post-MAA injection
Heart Liver Tumour (left lobe)
MAA a p a 1p a p1
Pre-injection 0.42±0.15 1.92± 1.60 0.51±0.15 1.33± 1.20 0.58±0.16 2.36±2.20
Post-injection 0.36±0.09 0.88±0.71 0.43±0.16 0.39±0.19 0.42±0.13 0.56±0.58
Note:a is the intercept of the exponentially fitted curve at time zero. P is the slope of the
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Figure 3 Liver cells with double nuclei and deeper cytoplasmic
staining in the normal liver tissue adjacent to the tumour indicate
regeneration. H and E, x 40. Figure 4 Obvious degeneration of liver cells in the area sur-
rounding the vein accompanied by dilatation of the cavity and
congestion caused by MAA microspheres intraarterial embolisa-
tion. H and E, x 10.
Table III Summary ofhistological examination ofrabbit VX2 liver cancer on the 7th day
after treatment
Necrosis of Fibroplasia Adjacent liver cells
Group Treatment tumour around tumour Degeneration Regeneration
1 Control + + +
2 MAA alone + + + +
3 MAA+MISO ++ ++ ++ +
4 MAA+ 15Gy +++ +++ ++ ++
5 MAA+MISO+15Gy ++++ ++++ ++ ++
Note: Thescorefornecrosis oftumour: + Spot; + + Patch; + + + Largepatch; + + + +
Complete with formation of cavity. Fibroplasia around tumour: + Slight fibrosis; + +
Moderate fibroplasia; + + + Obvious and encircling fibroplasia; + + + + Remarkable and
encircling fibroplasia. Degeneration or regeneration of adjacent liver cells: + slight; + +
obvious.
Discussion
In this study the greatest tumour response was obtained by
regional infusion of 10 mg MISO followed by 15 Gy irradia-
tion following MAA intraarterial embolisation. This was true
both in terms of the tumour volume and histological examin-
ation endpoints. Many investigators have demonstrated that
the blood supply to tumours in the liver comes mainly from
the hepatic artery and that some tumours are hypervascular
relative to normal liver (Gyves et al., 1984). The density of
vessels in the tumour region appears to be 2- to 6-fold
greater than that in normal liver (Esminger & Gyves, 1984).
This characteristic suggests a route to selective therapeutic
advantage. Microspheres of 30-40tm (range 10-90jLm) in
diameter should lodge in the hepatic-arterial microvas-
culature when injected into the common hepatic artery.
Chamberlain and Gray (1983) demonstrated that in rabbit
VX2 liver tumours, the concentration of microspheres was
30-fold higher than in the normal liver tissues. Therefore in
hypervascular regions of tumours the aterial capillary ob-
struction and the slowdown of blood flow rate result in the
entrapment of a greater volume of drug solution than in
normal liver. This eventually results in higher regional drug
concentration and consequently intensifies drug exposure
(Sigurdson et al., 1986). Chen and Gross (1980) demon-
strated that the regional drug exposure advantage for agents
with linear pharmacokinetics is related to the blood flow rate
of the infusing artery and the rate of drug elimination by the
rest of the body. In our data for 9'9Tc regional clearance
after MAA injection the value ofa decreased slightly suggest-
ing that the initial drug takeup might be lower (for heart, it
might indicate that the washout rate of the tracer from the
liver was slowed down). However the P value for those
regions dropped markedly particularly in the tumour. This
appreciable divergence shows that there is a higher tumour/
systemic concentration ratio for MISO. During recent years
there has been considerable progress in the radiosensitiser
research field. However, after many experimental and clinical
studies, it became clear that MISO had a limited future
owing to its neurological complications which limited the
clinically achievable dose. Our results suggest that low dose
regional infusion of MISO following hepatic arterial
embolisation may represent a new strategy for its clinical use
by targeting radiosensitisation. Several experimental studies
have shown MISO to be a selective cytotoxic agent for
hypoxic cells (Adams, 1988). There were noticeable tumour
responses to 10 mg MISO infused via the hepatic artery
following embolisation without irradiation, as shown in
Table III. These were characterised by smaller tumour
volume (P<0.1) and more obvious necrosis of the tumour
with surrounding fibroplasia compared with the group which
had received embolisation alone. This effect demonstrates
that the hypoxia induced by interruption of blood flow might
provide a favourable environment for the regional admini-
stration of MISO. Based on our results, the advantages of
regional infusion of MISO following hepatic-arterial
embolisation would appear to be: (1) Selectively increased
radiosensitivity of liver cancer along with very low drug
concentration in the plamsa, (2) Reduced or eliminated
deleterious side effects of MISO with higher tumour/systemic
ratios of drug concentration, (3) Reduced cost due to lower
dosage of MISO required for regional infusion.
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